38
Participants
Start Date
September 16, 2014
Primary Completion Date
December 19, 2018
Study Completion Date
February 24, 2019
Specialized tumor board recommendation
A combination of up to four FDA approved drugs based on the molecular profile of the patient's tumor as determined by gene expression analysis, WES and predictive modeling.
Standard radiation therapy
Initial therapy will consist of standard radiation therapy per institutional guidelines followed by molecular based therapy with FDA approved drugs.
Children's National Medical Center, Washington D.C.
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
University of Utah, Salt Lake City
Rady Children's Hospital, San Diego
University of California, San Francisco, San Francisco
Translational Genomics Research Institute
OTHER
University of California, San Francisco
OTHER